United States · FDA National Drug Code directory

Lisinopril and Hydrochlorothiazide

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 68645-556_4c4ae743-258c-e380-e063-6394a90af48a
Product NDC: 68645-556
Form: TABLET
Composition / generic term: Lisinopril and Hydrochlorothiazide
Labeler: Legacy Pharmaceutical Packaging, LLC
Marketing category: ANDA
Marketing start / end (source format): 20061004
Source listing expiry: 20271231

Source-listed ingredients

HYDROCHLOROTHIAZIDE — 12.5 mg/1
LISINOPRIL — 10 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

30 TABLET in 1 BOTTLE (68645-556-54) · 68645-556-54

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →